CEO and Member of the Board of Directors, Allarity Therapeutics A/S
Bio
30+ years of commercial industry experience focused in oncology, including former CEO roles at Apexian Pharmaceuticals, Raphael Pharmaceuticals (formerly Cornerstone Pharmaceuticals), and Senior Vice President and President, Commercial Operations (North America) for Mallinckrodt Pharmaceuticals, leading the company listing on NYSE. Earlier in his career, he held senior leadership positions at General Electric, Johnson & Johnson, Eli Lilly & Company and Bristol Myers Squibb.